Introduction {#Sec1}
============

Cardiovascular diseases are currently the leading cause of death in humans \[[@CR1]--[@CR5]\]. The high mortality of cardiac diseases is associated with myocardial ischemia and reperfusion (I/R) \[[@CR5]\]. Myocardial I/R is a pathological state featured by an initial limitation on the blood supply to the heart, followed by blood reperfusion and recovery of oxygen supply \[[@CR6]\]. The recovery of blood supply and reoxygenation are always associated with increased tissue damage and inflammatory responses, which are known as reperfusion injury \[[@CR1], [@CR2]\]. Moreover, I/R injury may affect the treatment efficiency of cardiac diseases, which could cause severe cell dysfunction, such as apoptosis and necrosis \[[@CR6]\]. However, cardiomyocytes are terminally differentiated cells that endogenous regenerative capacity of maintaining cell function is insufficient during severe injury \[[@CR7]\]. Therefore, inhibition of cardiomyocyte apoptosis may have promised as a therapeutic strategy for I/R injury. Recent studies have made some progress on mechanisms of myocardial I/R injury. However, clinical treatments are accompanied by low cure rate. Therefore, the molecular mechanisms of myocardial I/R injury remain to be further explored.

MicroRNAs (miRNAs) are small, highly conserved, and non-coding RNA, which containing approximately 22 nucleotides \[[@CR8]--[@CR10]\]. MiRNAs promote the degradation of mRNA or inhibit the translation of mRNA by targeting the 3′ untranslated region of mRNA, thereby regulating gene expression at post-transcriptional level \[[@CR10]--[@CR12]\]. MiRNAs are dominant players in different aspects of cardiovascular development \[[@CR10]\], including cell apoptosis, cell proliferation, and differentiation \[[@CR13]--[@CR15]\]. Our previous studies by RNA sequencing found that a long non-coding RNA is involved in ischemia and reperfusion injury. Furthermore, we found by database prediction that miR-141-3p is one of the downstream of this long non-coding RNA (data not shown). Previous studies reported that miR-141-3p is associated with glioma cell growth \[[@CR16]\], mesenchymal stem cell aging \[[@CR17]\], and I/R injury in endothelial cells \[[@CR18]\]. However, the roles and mechanisms of miR-141-3p in myocardial I/R injury or in hypoxia/reoxygenation (H/R) in vitro model remain to be elucidated.

Chromodomain helicase DNA-binding protein 8 (CHD8) is a member of ATP-dependent chromatin remodeling protein in the CHD family \[[@CR19]\]. CHD8 is related to the development of autism \[[@CR20], [@CR21]\], and involved in embryonic development and apoptosis of vascular smooth muscle cells \[[@CR19], [@CR22]\]. However, the function of CHD8 in myocardial I/R injury and H/R is not known yet.

P21, the well-known cyclin-dependent kinase inhibitor, is a 165 amino acids protein that confirmed to play an important role in inhibition of cell cycle, suppression of tumor progress and cell apoptosis \[[@CR23], [@CR24]\]. Recent studies have reported p21 served as a pro-apoptosis regulator in cardiomyocytes \[[@CR25]\]. But the further mechanism still needs to be elucidated.

It has been well established that in vitro H/R model can follow in vivo myocardial I/R injury \[[@CR26], [@CR27]\]. In the current study, we performed the hypoxia/reoxygenation model, one that has been widely used to investigate the mechanisms of myocardial I/R injury \[[@CR26], [@CR27]\]. We found that the expression of miR-141-3p attenuates cardiomyocyte apoptosis induced by H/R. Additionally, downregulation of CHD8 inhibits cardiomyocyte apoptosis induced by H/R. Furthermore, we found miR-141-3p and CHD8 reduce p21 expression. Thus, our studies may provide a novel potential therapeutic target against myocardial I/R injury-induced cardiovascular diseases.

Materials and methods {#Sec2}
=====================

Cell culture {#Sec3}
------------

H9c2 cardiomyocytes were obtained from the Cell Bank of Shanghai Institute of Cell Biology, Chinese Academy of Sciences. The cells were cultured with basic Dulbecco\'s modified Eagle\'s medium (DMEM) containing 10% fetal bovine serum. Cultures were incubated at 37 °C and 5% CO~2~ in a fully humidified incubator.

The hypoxia/reoxygenation cell culture model {#Sec4}
--------------------------------------------

To establish the hypoxia/reoxygenation in vitro model, H9c2 cardiomyocytes were cultured with low glucose (1 mg/mL glucose) DMEM and incubated in an oxygen-free atmosphere (95% N~2~ and 5% CO~2~, 37 °C). After 8 h of culture, the cells were changed to a normal culture medium (4.5 mg/mL glucose) and normal atmosphere (95% air and 5% CO~2~, 37 °C) for another 48 h. Cells in the control group were cultured under normal conditions.

RNA isolation, reverse transcription and real-time quantitative RT-PCR (qRT-PCR) analysis {#Sec5}
-----------------------------------------------------------------------------------------

The qRT-PCR was performed as described previously by our work \[[@CR28]\]. Briefly, total RNA in H9c2 cells were extracted using TRIzol reagent (Cwbio, Beijing, China). Reverse transcription 1 μg RNA per sample using miDETECT A Track™ miRNA qRT-PCR Starter Kit (RiboBio Co., Ltd, Guangzhou, China) to synthetic cDNA to detect miR-141-3p. While using PrimeScript™ RT reagent Kit (Perfect Real Time) (Takara, Japan) for other mRNAs. PCR analysis was executed using iTaq™ universal SYBR® Green Supermix (Bio-Rad, Hercules, CA). Expression level of miR-141-3p was detected using U6 as internal control, while expression levels of other mRNAs were detected using GAPDH as internal control. The primer sequences used are listed in Table [1](#Tab1){ref-type="table"}.Table 1Primers used for qRT-PCRGeneForward primer sequence (5′--3′)Reverse primer sequence (5′--3′)NCBI accession IDLength of the ampliconsmiR-141-3pThe primer sequences are proprietary information of the company. (RiboBio Co., Ltd, Guangzhou, China)U6ATTGGAACGATACAGAGAAGATTGGAACGCTTCACGAATTTGK0078470 bpCHD8CCTCACGCACTGCTTCACCATCCTCCTAGCCACCACCTCATCCTCNM_001347661133 bpGAPDHGGTGGACCTCATGGCCTACACTCTCTTGCTCTCAGTATCCTTGCTNM_017008.484 bp

Western blot analysis {#Sec6}
---------------------

Western blot analysis was performed as previous described \[[@CR29]\]. Briefly, total protein was extracted from the cells using RIPA lysis buffer (Cwbio, Beijing, China), which was added with Protease Inhibitor Cocktail (1%, v/v) (Cwbio, Beijing, China). Then proteins were separated by 8% and 12% SDS-PAGE gels and electrotransfer onto Immobilon PVDF membranes (Merck KGaA, Darmstadt, Germany). After blocking the membranes with fat free milk, the membranes were incubated overnight at 4 °C with primary antibodies (Table [2](#Tab2){ref-type="table"}). After incubation with secondary antibodies (goat anti-rabbit IgG, Proteintech, China), membranes were then imaged by an enhanced chemiluminescent detection kit (Cwbio, Beijing, China).Table 2Antibodies used for Western blottingNameDescriptionManufacturerAnti-β-actinRabbit monoclonal, 43 kDaProteintech (20,536--1-AP)Anti-Caspase-3Rabbit monoclonal, 34 kDaCST (\#9662S)Anti-Cleaved caspase-3Rabbit monoclonal, 16 kDaCST (\#9664S)Anti-CHD8Rabbit monoclonal, 290 kDaCST (\#77,694)Anti-p21Rabbit monoclonal, 21 kDaAbcam (109,199)

Cell apoptosis detection by flow cytometric analysis {#Sec7}
----------------------------------------------------

Flow cytometric analysis was performed as previous described by us \[[@CR30]\]. Apoptotic cells were determined by flow cytometer (Becton, Dickinson and Company, CA, USA) and the percentage of apoptotic cells was determined by FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, Franklin Lakes, NJ, USA). Cells were gathered according to the manufacturer's instructions and cells were rinsed twice with cold PBS and then resuspended in binding buffer at a concentration of 1 × 10^6^ cells/ mL. 100 µl of the solution (1 × 10^5^ cells) was transferred to per culture tube, 5 µl of FITC Annexin V and 5 µl PI were added subsequently. Then, the cells were gently vortexed and incubated for 15 min at RT in the dark. Finally, 400 µl of binding buffer were putted into each tube and analyzed by flow cytometry within 1 h.

Transfection of overexpression mimics or siRNA {#Sec8}
----------------------------------------------

Mimics and small interfering RNA transfection (siRNA) were performed as described previously by us \[[@CR31]\]. Briefly, H9c2 cells were cultured in 6-wells plates. To overexpression of miR-141-3p, when H9c2 cells were visualized at 40% density, transient transfected with miR-141-3p mimics or miR-141-3p negative control (miR-141-3p NC) (GenePharma, Shanghai, China) using Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instruction. After 48 h culture, H9c2 cells were harvested for H/R treatment or further study. The miR-141-3p mimics and miR-141-3p NC sequences used are as follows:

miR-141-3p mimics: 5′-UAACACUGUCUGGUAAAGAUGG-3′;

miR-141-3p negative control: 5′-ACGUGACACGUUCGGAGAATT-3′;

Similarly, to knockdown the expression of CHD8, siRNA oligonucleotides against CHD8 and negative control siRNA (NC-Si) were designed and synthesized by the RiboBio Co., Ltd. (Guangzhou, China). H9c2 cells were transient transfected with a mixture of siRNA using Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA) after observed at 40% density. After 48 h culture, the knockdown efficiency was determined by Western blot analysis and for further study. The siRNA sequences used are as follows:

CHD8-siRNA: 5′-CGATGTTACTGGTCCAATA-3′;

Negative control siRNA: 5′-TTCTCCGAACGTGTCACGT-3′.

RNA immunoprecipitation (RIP) {#Sec9}
-----------------------------

RIP was carried out using CHD8 antibody and the IgG antibody, which was served as negative control \[[@CR32]\]. Briefly, the cells were harvested by RIPA lysis buffer containing Protease Inhibitor Cocktail and RiboLock RNase inhibitor (1%, v/v) (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacture's instruction. Obtained samples were incubated for 1 h at 4 °C. Then, Protein A/G PLUS-Agarose was added into the samples and rotated overnight at 4 °C. Beads were washed for 4 times using lysis buffer. Finally, divided the samples into two equal parts respectively. One for Western blot analysis to determined expression level of CHD8, and the other for qRT-PCR analysis to detect expression level of miR-141-3p.

Statistical analysis {#Sec10}
--------------------

Graphpad Prism 5.01 was used to analyze data in this study. The results were presented as mean ± SD. The data were analyzed using one-way analysis of variance and Student's t-test. A value of *P* \< 0.05 was considered to be statistically significant.

Results {#Sec11}
=======

MiR-141-3p is downregulated by hypoxia/reoxygenation (H/R) in H9c2 cardiomyocytes {#Sec12}
---------------------------------------------------------------------------------

To investigate whether miR-141-3p plays a role in H/R-induced injury in cardiomyocytes. We first evaluated the morphological alterations of H9c2 cardiomyocytes following H/R and observed that H/R promoted cell damage and reduced the number of H9c2 cardiomyocytes (Fig. [1](#Fig1){ref-type="fig"}a). We then determined the expression level of miR-141-3p following H/R treatment by real-time quantitative RT-PCR (qRT-PCR). As shown in Fig. [1](#Fig1){ref-type="fig"}b, the expression level of miR-141-3p was dramatically decreased in H9c2 cardiomyocytes following H/R treatment, indicating that miR-141-3p might be involved in cardiomyocyte H/R injury.Fig. 1MiR-141-3p is downregulated by hypoxia/reoxygenation (H/R) in H9c2 cardiomyocytes. H9c2 cardiomyocytes were subjected to hypoxia treatment for 8 h with low glucose (1 mg/mL glucose) DMEM and oxygen-free atmosphere (95% N~2~ and 5% CO~2~, 37 °C), then reoxygenated for 48 h with normal culture medium (4.5 mg/mL glucose) and normal atmosphere (95% air and 5% CO~2~, 37 °C). **a** The alteration of morphology was observed by microscope. **b** The expression of miR-141-3p was determined by qRT-PCR. N = 3 per group. \**P* \< 0.05, compared with control group

Overexpression of miR-141-3p dramatically decreases H/R-induced H9c2 cardiomyocyte apoptosis {#Sec13}
--------------------------------------------------------------------------------------------

To determine whether miR-141-3p contributed to H/R induced cardiomyocyte apoptosis, we examined the alterations of apoptotic marker cleaved caspase-3 (Cl-caspase-3) protein and also performed flow cytometric analysis in H9c2 cardiomyocytes after transfection with miR-141-3p mimics. We found that overexpression of miR-141-3p significantly inhibited H/R-induced Cl-caspase-3 (Fig. [2](#Fig2){ref-type="fig"}a) and apoptosis in H9c2 cardiomyocytes (Fig. [2](#Fig2){ref-type="fig"}b). Taken together, these results reveal that miR-141-3p plays a critical role in cardiomyocyte apoptosis induced by H/R.Fig. 2Overexpression of miR-141-3p decreases H/R induced apoptosis in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with miR-141-3p mimics or miR-141-3p NC for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. Transfected H9c2 cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. [1](#Fig1){ref-type="fig"}. **a** The cleaved caspase-3 (Cl-caspase-3) and caspase-3 were measured by Western blot analysis. **b** Apoptotic cells were determined by flow cytometric analysis. N = 3 per group. *NC* negative control. \**P* \< 0.05, \*\**P* \< 0.01, compared with indicated groups

H/R induces the expression of CHD8 in H9c2 cardiomyocytes {#Sec14}
---------------------------------------------------------

We then evaluate whether the expression of CHD8 was altered following H/R. Our results showed that H/R significantly increased CHD8 expression in both protein and mRNA levels in H9c2 cardiomyocytes (Fig. [3](#Fig3){ref-type="fig"}a, b), indicating that CHD8 may participate in cardiomyocyte apoptosis induced by H/R.Fig. 3CHD8 is upregulated by H/R in H9c2 cardiomyocytes. H9c2 cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. [1](#Fig1){ref-type="fig"}. **a** The expression of CHD8, Cl-caspase-3, and caspase-3 was examined by Western blot. **b** CHD8 miRNA expression was determined by qRT-PCR. N = 3 per group. \**P* \< 0.05, \*\**P* \< 0.01, compared with control group

Downregulation of CHD8 inhibits H9c2 cardiomyocyte apoptosis induced by H/R {#Sec15}
---------------------------------------------------------------------------

To assess the role of CHD8 in H/R induced apoptosis, H9c2 cardiomyocyte were transfected with small interfering RNA (siRNA). As shown in Fig. [4](#Fig4){ref-type="fig"}a, inhibition of CHD8 significantly decreased the expression level of Cl-caspase-3 induced by H/R. Moreover, we performed flow cytometry analysis and found that inhibition of CHD8 dramatically diminished the number of cardiomyocyte apoptosis induced by H/R (Fig. [4](#Fig4){ref-type="fig"}b). These results demonstrated that knockdown of CHD8 could ameliorate H/R induced cardiomyocyte apoptosis.Fig. 4Knockdown of CHD8 inhibits apoptosis induced by H/R in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with CHD8-siRNA (CHD8-Si) or negative control-siRNA (NC-Si) for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. Transfected H9c2 cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. [1](#Fig1){ref-type="fig"}. **a** The expression of Cl-caspase-3 and caspase-3 was determined by Western blot. **b** Apoptotic cells were determined by flow cytometric analysis. N = 3 per group. \**P* \< 0.05, \*\**P* \< 0.01, compared with indicated groups

MiR-141-3p interacts with CHD8 in H9c2 cardiomyocytes {#Sec16}
-----------------------------------------------------

We then examined whether there is interaction between miR-141-3p and CHD8. We showed that overexpression of miR-141-3p reduced the expression of CHD8 in both protein and mRNA levels (Fig. [5](#Fig5){ref-type="fig"}a, b). Interestingly, inhibition of CHD8 increased the expression level of miR-141-3p (Fig. [5](#Fig5){ref-type="fig"}c). Therefore, we examined the relationship between them by RIP analysis. Collected H9c2 cardiomyocytes were extracted by RIPA lysis buffer. As shown in Fig. [5](#Fig5){ref-type="fig"}d, e, qRT-PCR and Western blot analysis showed the relationship between miR-141-3p and CHD8. In addition, we didn't find complementary base pairs of miR-141-3p and CHD8 mRNA by searching for TargetScan (data not shown). Collectively, these findings suggested that there is an indirect interaction between miR-141-3p and CHD8 in H9c2 cardiomyocytes.Fig. 5MiR-141-3p interacts with CHD8 in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with miR-141-3p mimics or miR-141-3p NC for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. CHD8 expression was examined by Western blot (**a**) and qRT-PCR (**b**). **c** H9c2 cardiomyocytes were transfected with CHD8-siRNA (CHD8-Si) or negative control-siRNA (NC-Si) for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. The expression of miR-141-3p was examined by qRT-PCR. The relationship between miR-141-3p and CHD8 was determined by RIP analysis (d, e). Collected H9c2 cardiomyocytes were extracted by RIPA lysis buffer. Obtained samples were pre-incubated with protein A/G PLUS-agarose. The samples were then divided into two parts equally and incubated with IgG and CHD8 overnight separately. Washed samples and then divided each sample into two parts, one for Western blot analysis and the other for qPCR analysis. **d** The expression level of miR-141-3p was measured by qRT-PCR. **e** The protein expression level of CHD8 was examined by Western blot analysis. N = 3 per group. *NC* negative control. \**P* \< 0.05, \*\**P* \< 0.01, compared with indicated groups

MiR-141-3p and CHD8 can reduce the expression of p21 in H9c2 cardiomyocytes {#Sec17}
---------------------------------------------------------------------------

Previous study has shown that p21 could act as an apoptosis promoting regulator \[[@CR25]\]. We therefore investigated that whether miR-141-3p or CHD8 plays a role in alteration of p21 expression. Notably, we found that either overexpression of miR-141-3p or inhibition of CHD8 significantly decreased the expression of p21 (Fig. [6](#Fig6){ref-type="fig"}a, b). We further determined whether miR-141-3p or CHD8 had effect on p21 expression following H/R. Our results showed that the expression of p21 was decreased after transfection with miR-141-3p mimics or CHD8-Si following H/R treatment (Fig. [6](#Fig6){ref-type="fig"}c, d). Therefore, these results suggest that p21 contributes to miR-141-3p and CHD8 mediated signaling in H/R.Fig. 6MiR-141-3p and CHD8 reduce the expression level of p21 in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with miR-141-3p mimics or CHD8-Si for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. **a** P21 expression was examined by Western blot. **b** The expression of p21 and CHD8 was determined by Western blot. After transfected with miR-141-3p mimics or CHD8-Si as a, b, H9c2 cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. [1](#Fig1){ref-type="fig"}. **c**, **d** P21 expression was examined by Western blot. N = 3 per group. \**P* \< 0.05, \*\**P* \< 0.01, compared with indicated groups

Discussion {#Sec18}
==========

To the best of our knowledge, the results of this study reveal for the first time that miR-141-3p is downregulated and exerts as a protective regulator against H/R induced cardiomyocyte apoptosis. Subsequently, CHD8 is verified to act as a pro-apoptotic molecular in H/R induced cardiomyocyte apoptosis. Meanwhile, miR-141-3p and CHD8 regulate the expression of p21. These studies reveal that miR-141-3p, a potential target of myocardial I/R injury, may provide a novel therapeutic strategy on cardiac diseases, which based on interacting with CHD8.

Myocardial I/R injury has become a prominent problem that influences therapeutical effect of reperfusion therapy on ischemic myocardium \[[@CR33]\]. Further, reperfusion accelerates the process of apoptosis induced by ischemia itself \[[@CR34]\]. Due to the apoptosis of cardiomyocytes in the ischemic site occurs immediately, it causes enrichment of reactive oxygen species with reperfusion progressing, which eventually aggravates the degree of apoptosis \[[@CR35], [@CR36]\]. Thus, it's well established that ameliorating apoptosis plays a pivotal role against I/R injury.

Increasing number of miRNAs, such as miR-25 and miR-762 modulate the expression of key molecular associated with apoptosis in myocardial I/R injury \[[@CR37], [@CR38]\]. Previous studies have shown that miR-141-3p alters the expression of p53 as a reason of promoting glioblastoma progression and temozolomide resistance \[[@CR16]\]. MiR-141-3p also has impact on mesenchymal stem cell senescence by directly targeting ZMPSTE24 \[[@CR17]\]. MiR-141 decreases myocardial I/R injury in endothelium by regulating expression of ICAM-1 \[[@CR18]\]. In our study, the results showed that the expression of miR-141-3p is significantly downregulated and overexpression of miR-141-3p alleviates the cardiomyocyte apoptosis induced by H/R.

CHD8 is a protective molecular in apoptosis. It decreased p53-mediated apoptosis during early embryogenesis \[[@CR22]\]. In addition, it was also confirmed to act as an inhibitor of apoptosis in A10 vascular smooth muscle cells \[[@CR19]\]. Surprisingly, the results of our study showed that the expression of CHD8 is increased and it promotes H9c2 cardiomyocyte apoptosis following H/R. Our study unveiled for the first time that CHD8 plays an important role in cardiomyocyte apoptosis, which also indicates its significant function in cardiac diseases. Our results from Western blot, qPCR, and RIP analysis all showed that miR-141-3p and CHD8 have effects on each other. However, we could not find complementary sequences between them by bioinformatic analysis. Our data suggest that other protein(s) may mediate between them, which will be investigated in our future studies.

Previous studies have reported that p21 served as a regulator of anti-apoptosis \[[@CR39], [@CR40]\], while other studies verified its pro-apoptotic effect \[[@CR25]\]. It inhibits the activation of cell cycle which is necessary to initiate apoptosis. Otherwise, under certain conditions, p21 promotes cell apoptosis in either p53-dependent or p53-independent mechanisms \[[@CR41]\]. In our current study, the results reveal for the first time that the expression of p21 is regulated by miR-141-3p and CHD8. But it still remains further studies that whether the effects of miR-141-3p and CHD8 in H/R induced apoptosis is through p21. We recognize that the limitation of this study was that only a single cell line and more cell lines will be determined in our future studies.

Conclusion {#Sec19}
==========

In summary, this is the first study to provide evidence illustrating that the expression of miR-141-3p attenuates cardiomyocyte apoptosis induced by H/R by interacting with CHD8. Our findings indicated that the mechanism underlying miR-141-3p and CHD8 interaction in H/R induced cardiomyocyte apoptosis may provide a novel therapeutic strategy against myocardial I/R injury-induced cardiovascular diseases.
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